PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279775
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279775
Global Health Self-Monitoring Technologies Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Self-monitoring is a recent development in personal health where people utilise software and electronic devices to gather, process, and present a variety of personal data to aid in managing and monitoring their own health. Recent technological advancements make self-tracking easier. The Health Self-Monitoring Technologies market is expanding because of factors such as rising prevalence of acute diseases such as diabetes and chronic disease and growing Geriatric Population.
Rising prevelance of acute diseases such as diabetes and chronic disease across the world is fostering the market growth, according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Furthermore, according to Robert Wood Johnson Foundation, in year 2020, the incidences of chronic illness in United States stood at 157 million cases which is projected to increase and reach at 171 million cases by year 2030. In addition, high time requires for the physical tests and rising technological advancement is creating a lucurative growth to the market. However, high cost of health self-monitoring technologies may hamper the market growth.
The key regions considered for the Global Health Self-Monitoring Technologies Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologys and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable